BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158:570-87. [PMID: 2842405 DOI: 10.1093/infdis/158.3.570] [Cited by in Crossref: 161] [Cited by in F6Publishing: 154] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Ramig RF, Ward RL. Genomic segment reassortment in rotaviruses and other reoviridae. Adv Virus Res 1991;39:163-207. [PMID: 1645493 DOI: 10.1016/s0065-3527(08)60795-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
2 Flores J, Perez-Schael I, Blanco M, Rojas AM, Alfonzo E, Crespo I, Cunto W, Pittman AL, Kapikian AZ. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol 1993;31:2439-45. [PMID: 8408569 DOI: 10.1128/jcm.31.9.2439-2445.1993] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Feikin DR, Laserson KF, Ojwando J, Nyambane G, Ssempijja V, Audi A, Nyakundi D, Oyieko J, Dallas MJ, Ciarlet M, Neuzil KM, Breiman RF. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya. Vaccine 2012;30:A52-60. [DOI: 10.1016/j.vaccine.2011.08.043] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
4 Offit PA. The rotavirus vaccine. J Clin Virol 1998;11:155-9. [PMID: 9949951 DOI: 10.1016/s0928-0197(98)00063-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Offit PA. Immunologic Determinants of Protection Against Rotavirus Disease. In: Ramig RF, editor. Rotaviruses. Berlin: Springer Berlin Heidelberg; 1994. pp. 229-54. [DOI: 10.1007/978-3-642-78256-5_8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
6 Mast TC, Walter EB, Bulotsky M, Khawaja SS, Distefano DJ, Sandquist MK, Straus WL, Allen Staat M. Burden of Childhood Rotavirus Disease on Health Systems in the United States: Results From Active Surveillance Before Rotavirus Vaccine Introduction. Pediatric Infectious Disease Journal 2010;29:e19-25. [DOI: 10.1097/inf.0b013e3181ca7e2e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
7 Dennehy PH. Rotavirus vaccines--an update. Vaccine. 2007;25:3137-3141. [PMID: 17321017 DOI: 10.1016/j.vaccine.2007.01.102] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
8 Chen CC, Chang CJ, Lin TY, Lai MW, Chao HC, Kong MS. Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea. World J Gastroenterol 2011; 17(37): 4218-4224 [PMID: 22072854 DOI: 10.3748/wjg.v17.i37.4218] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
9 Clark HF, Offit PA, Plotkin SA, Heaton PM. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants. Pediatr Infect Dis J 2006;25:577-83. [PMID: 16804425 DOI: 10.1097/01.inf.0000220283.58039.b6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
10 Ward RL, McNeal MM, Steele AD. Why does the world need another rotavirus vaccine? Ther Clin Risk Manag 2008;4:49-63. [PMID: 18728720 DOI: 10.2147/tcrm.s821] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
11 Ward RL, Greenberg HB, Estes MK. Viral Gastroenteritis Vaccines. Mucosal Immunology. Elsevier; 2005. pp. 887-903. [DOI: 10.1016/b978-012491543-5/50053-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Andrew ME, Boyle DB, Coupar BE, Reddy D, Bellamy AR, Both GW. Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine 1992;10:185-91. [PMID: 1313627 DOI: 10.1016/0264-410x(92)90010-h] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
13 Ward RL, Bernstein DI. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 1995;13:1226-32. [DOI: 10.1016/0264-410x(95)00060-e] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
14 Vesikari T, Kapikian AZ. Rotavirus Vaccine Development. In: Kurstak E, editor. Modern Vaccinology. Boston: Springer US; 1994. pp. 213-29. [DOI: 10.1007/978-1-4899-1450-7_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis 1998;4:561-70. [PMID: 9866732 DOI: 10.3201/eid0404.980406] [Cited by in Crossref: 222] [Cited by in F6Publishing: 198] [Article Influence: 10.1] [Reference Citation Analysis]
16 Hauber AB, Itzler R, Johnson FR, Mohamed AF, González JM, Cook JR, Walter EB. Healthy-days time equivalents for outcomes of acute rotavirus infections. Vaccine 2011;29:8086-93. [PMID: 21864612 DOI: 10.1016/j.vaccine.2011.08.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
17 Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gómara M, Johne R, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Parreño V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 2011;156:1397-413. [PMID: 21597953 DOI: 10.1007/s00705-011-1006-z] [Cited by in Crossref: 655] [Cited by in F6Publishing: 603] [Article Influence: 65.5] [Reference Citation Analysis]
18 Huppertz HI, Forster J, Heininger U, Roos R, Neumann HU, Hammerschmidt T. The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila) 2008;47:363-71. [PMID: 18270310 DOI: 10.1177/0009922807310933] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
19 Huys A, Grau KR, Karst SM. Development of Oral Rotavirus and Norovirus Vaccines. Mucosal Vaccines. Elsevier; 2020. pp. 699-712. [DOI: 10.1016/b978-0-12-811924-2.00040-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ward RL, Mcneal MM, Sheridan JF. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 1992;188:57-66. [DOI: 10.1016/0042-6822(92)90734-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 1.8] [Reference Citation Analysis]
21 Richardson SC, Grimwood K, Bishop RF. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. J Clin Microbiol 1993;31:377-85. [PMID: 8381813 DOI: 10.1128/jcm.31.2.377-385.1993] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
22 Offit PA. Challenges to Developing a Rotavirus Vaccine. Viral Immunol 2018;31:104-8. [PMID: 29265955 DOI: 10.1089/vim.2017.0121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Johansen K, Hinkula J, Espinoza F, Levi M, Zeng C, Rud�n U, Vesikari T, Estes M, Svensson L. Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus. J Med Virol 1999;59:369-77. [DOI: 10.1002/(sici)1096-9071(199911)59:3<369::aid-jmv18>3.0.co;2-n] [Cited by in Crossref: 37] [Article Influence: 1.7] [Reference Citation Analysis]
24 Ruuska T, Vesikari T, Delem A, André FE, Beards GM, Flewett TH. Evaluation of RIT 4237 Bovine Rotavirus Vaccine in Newborn Infants: Correlation of Vaccine Efficacy to Season of Birth in Relation to Rotavirus Epidemic Period. Scandinavian Journal of Infectious Diseases 2009;22:269-78. [DOI: 10.3109/00365549009027047] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
25 Ciarlet M, Crawford SE, Barone C, Bertolotti-ciarlet A, Ramig RF, Estes MK, Conner ME. Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity. J Virol 1998;72:9233-46. [DOI: 10.1128/jvi.72.11.9233-9246.1998] [Cited by in Crossref: 97] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
26 Desselberger U. Prospects for vaccines against rotaviruses. Rev Med Virol 1998;8:43-52. [PMID: 10398493 DOI: 10.1002/(sici)1099-1654(199801/03)8:1<43::aid-rmv206>3.0.co;2-o] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Nakagomi O, Isegawa Y, Ward RL, Knowlton DR, Kaga E, Nakagomi T, Ueda S. Naturally occurring dual infection with human and bovine rotaviruses as suggested by the recovery of G1P8 and G1P5 rotaviruses from a single patient. Arch Virol 1994;137:381-8. [PMID: 7944957 DOI: 10.1007/BF01309483] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Gouvea V, Lima RC, Linhares RE, Clark H, Nosawa CM, Santos N. Identification of two lineages (WA-like and F45-like) within the major rotavirus genotype P[8]. Virus Research 1999;59:141-7. [DOI: 10.1016/s0168-1702(98)00124-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
29 Unicomb LE, Faruque SM, Malek MA, Faruque AS, Albert MJ. Demonstration of a lack of synergistic effect of rotavirus with other diarrheal pathogens on severity of diarrhea in children. J Clin Microbiol 1996;34:1340-2. [PMID: 8727937 DOI: 10.1128/jcm.34.5.1340-1342.1996] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Mestecky J, Abraham R, Ogra PL. Common Mucosal Immune System and Strategies for the Development of Vaccines Effective at the Mucosal Surfaces. Handbook of Mucosal Immunology. Elsevier; 1994. pp. 357-72. [DOI: 10.1016/b978-0-12-524730-6.50036-1] [Cited by in Crossref: 35] [Article Influence: 1.3] [Reference Citation Analysis]
31 Parez N. Rotavirus gastroenteritis: Why to back up the development of new vaccines? Comparative Immunology, Microbiology and Infectious Diseases 2008;31:253-69. [DOI: 10.1016/j.cimid.2007.07.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
32 Lee G, Peñataro Yori P, Paredes Olortegui M, Caulfield LE, Sack DA, Fischer-Walker C, Black RE, Kosek M. An instrument for the assessment of diarrhoeal severity based on a longitudinal community-based study. BMJ Open 2014;4:e004816. [PMID: 24907244 DOI: 10.1136/bmjopen-2014-004816] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
33 Choi AH, Knowlton DR, Mcneal MM, Ward RL. Particle Bombardment-Mediated DNA Vaccination with Rotavirus VP6 Induces High Levels of Serum Rotavirus IgG but Fails to Protect Mice against Challenge. Virology 1997;232:129-38. [DOI: 10.1006/viro.1997.8552] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
34 Perez-schael I, Blanco M, Vilar M, Garcia D, White L, Gonzalez R, Kapikian AZ, Flores J. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28:553-8. [DOI: 10.1128/jcm.28.3.553-558.1990] [Cited by in Crossref: 68] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
35 Clark HF, Offit PA, Ellis RW, Krah D, Shaw AR, Eiden JJ, Pichichero M, Treanor JJ. WC3 reassortant vaccines in children. Arch Virol Suppl 1996;12:187-98. [PMID: 9015115 DOI: 10.1007/978-3-7091-6553-9_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
36 Richardson SC, Bishop RF. Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus. J Clin Microbiol 1990;28:1891-7. [PMID: 2172292 DOI: 10.1128/jcm.28.9.1891-1897.1990] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
37 Chiba S. Immunological Aspects of Viral Gastroenteritis. In: Paradise LJ, Bendinelli M, Friedman H, editors. Enteric Infections and Immunity. Boston: Springer US; 1996. pp. 187-206. [DOI: 10.1007/978-1-4899-0313-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
38 Huet F, Chouchane M, Cremillieux C, Aubert M, Caulin E, Pothier P, Allaert FA. [Prospective epidemiological study of rotavirus gastroenteritis in Europe (REVEAL study). Results in the French area of the study]. Arch Pediatr 2008;15:362-74. [PMID: 18396016 DOI: 10.1016/j.arcped.2008.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
39 Brüssow H, Offit PA, Gerna G, Bruttin A, Sidoti J. Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J Virol 1990;64:4130-6. [PMID: 2166808 DOI: 10.1128/JVI.64.9.4130-4136.1990] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
40 Lecce JG, Leary HL, Clarke DA, Batema RP. Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11. J Clin Microbiol 1991;29:1382-6. [DOI: 10.1128/jcm.29.7.1382-1386.1991] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Clark A, van Zandvoort K, Flasche S, Sanderson C, Bines J, Tate J, Parashar U, Jit M. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect Dis 2019;19:717-27. [PMID: 31178289 DOI: 10.1016/S1473-3099(19)30126-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 20.0] [Reference Citation Analysis]
42 Mast TC, Chen P, Lu K, Hsu C, Lin HC, Liao W, Lin D, Chen H, Lac C. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005–2006. Vaccine 2010;28:3008-13. [DOI: 10.1016/j.vaccine.2010.02.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
43 Rojas AM, Boher Y, Guntinas MJ, Pérez-schael I. Homotypic immune response to primary infection with rotavirus serotype G1. J Med Virol 1995;47:404-9. [DOI: 10.1002/jmv.1890470418] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
44 Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, van Eijk A, Adegbola RA, Alonso PL, Breiman RF, Faruque AS, Saha D, Sow SO, Sur D, Zaidi AK, Biswas K, Panchalingam S, Clemens JD, Cohen D, Glass RI, Mintz ED, Sommerfelt H, Levine MM. The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 2012;55 Suppl 4:S232-45. [PMID: 23169936 DOI: 10.1093/cid/cis753] [Cited by in Crossref: 214] [Cited by in F6Publishing: 200] [Article Influence: 26.8] [Reference Citation Analysis]
45 Corcoran MS, van Well GT, van Loo IH. Diagnosis of viral gastroenteritis in children: interpretation of real-time PCR results and relation to clinical symptoms. Eur J Clin Microbiol Infect Dis 2014;33:1663-73. [PMID: 24828003 DOI: 10.1007/s10096-014-2135-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
46 Dennehy PH, Bresee JS. Rotavirus Vaccine and Intussusception. Infectious Disease Clinics of North America 2001;15:189-207. [DOI: 10.1016/s0891-5520(05)70275-0] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
47 Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002;34:1351-61. [PMID: 11981731 DOI: 10.1086/340103] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 6.5] [Reference Citation Analysis]
48 Bernstein DI. Rotavirus Vaccine: Current Status and Future Prospects. BioDrugs 2000;14:275-81. [DOI: 10.2165/00063030-200014050-00001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
49 Midthun K, Pang LZ, Flores J, Kapikian AZ. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates. J Clin Microbiol 1989;27:2799-804. [DOI: 10.1128/jcm.27.12.2799-2804.1989] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
50 Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schödel F, Ciarlet M, Neuzil KM. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:606-14. [PMID: 20692030 DOI: 10.1016/S0140-6736(10)60889-6] [Cited by in Crossref: 517] [Cited by in F6Publishing: 238] [Article Influence: 47.0] [Reference Citation Analysis]
51 Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. The Lancet Infectious Diseases 2008;8:642-9. [DOI: 10.1016/s1473-3099(08)70231-7] [Cited by in Crossref: 103] [Cited by in F6Publishing: 35] [Article Influence: 7.9] [Reference Citation Analysis]
52 Levine MM, Edelman R. Future Vaccines Against Enteric Pathogens. Infectious Disease Clinics of North America 1990;4:105-21. [DOI: 10.1016/s0891-5520(20)30326-3] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
53 Vesikari T, Ruuska T, Delem A, André FE, Beards GM, Flewett TH. Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea. Acta Paediatrica 1991;80:173-80. [DOI: 10.1111/j.1651-2227.1991.tb11830.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.2] [Reference Citation Analysis]
54 Riera-Montes M, O'Ryan M, Verstraeten T. Norovirus and Rotavirus Disease Severity in Children: Systematic Review and Meta-analysis. Pediatr Infect Dis J 2018;37:501-5. [PMID: 29135827 DOI: 10.1097/INF.0000000000001824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
55 Dharakul T, Labbe M, Cohen J, Bellamy AR, Street JE, Mackow ER, Fiore L, Rott L, Greenberg HB. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J Virol 1991;65:5928-32. [PMID: 1656079 DOI: 10.1128/JVI.65.11.5928-5932.1991] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
56 Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207-22. [PMID: 10403588 DOI: 10.1016/s0264-410x(98)00376-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
57 Levine MM, Noriega F. Vaccines to prevent enteric infections. Baillière's Clinical Gastroenterology 1993;7:501-17. [DOI: 10.1016/0950-3528(93)90051-s] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
58 Lamberti LM, Fischer Walker CL, Black RE. Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries. BMC Public Health 2012;12:276. [PMID: 22480268 DOI: 10.1186/1471-2458-12-276] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
59 Parsons KR, Hall GA, Bridger JC, Cook RS. Number and distribution of T lymphocytes in the small intestinal mucosa of calves inoculated with rotavirus. Vet Immunol Immunopathol 1993;39:355-64. [PMID: 7906907 DOI: 10.1016/0165-2427(93)90067-e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 Parashar UD, Cortese MM, Offit PA. Rotavirus Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 950-969.e11. [DOI: 10.1016/b978-0-323-35761-6.00051-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Offit PA, Dudzik KI. Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J Clin Microbiol 1989;27:885-8. [PMID: 2545743 DOI: 10.1128/jcm.27.5.885-888.1989] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
62 Ciarlet M, Hyser JM, Estes MK. Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3. Virus Genes 2002;24:107-18. [PMID: 12018701 DOI: 10.1023/a:1014512314545] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
63 Matthijnssens J, Joelsson DB, Warakomski DJ, Zhou T, Mathis PK, van Maanen M, Ranheim TS, Ciarlet M. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq®. Virology 2010;403:111-27. [DOI: 10.1016/j.virol.2010.04.004] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 8.6] [Reference Citation Analysis]
64 Lee GO, Richard SA, Kang G, Houpt ER, Seidman JC, Pendergast LL, Bhutta ZA, Ahmed T, Mduma ER, Lima AA, Bessong P, Jennifer MS, Hossain MI, Chandyo RK, Nyathi E, Lima IF, Pascal J, Soofi S, Ladaporn B, Guerrant RL, Caulfield LE, Black RE, Kosek MN; MAL-ED Network Investigators. A Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort Study. J Pediatr Gastroenterol Nutr 2016;63:466-73. [PMID: 27347723 DOI: 10.1097/MPG.0000000000001286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
65 Schnadower D, Tarr PI, Gorelick MH, O'Connell K, Roskind CG, Powell EC, Rao J, Bhatt S, Freedman SB. Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments. J Pediatr Gastroenterol Nutr. 2013;57:514-519. [PMID: 23676445 DOI: 10.1097/MPG.0b013e31829ae5a3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
66 Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, Guarino A, Szajewska H, Usonis V. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 2008;46 Suppl 2:S38-48. [PMID: 18460971 DOI: 10.1097/MPG.0b013e31816f7a10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
67 Green KY, Kapikian AZ. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol 1992;66:548-53. [DOI: 10.1128/jvi.66.1.548-553.1992] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
68 Haffejee I. The status of rotavirus vaccines in 1990. Journal of Infection 1991;22:119-28. [DOI: 10.1016/0163-4453(91)91481-c] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
69 Flores J, Kapikian AZ. Rotavirus Vaccines. Vaccines. Elsevier; 1992. pp. 255-88. [DOI: 10.1016/b978-0-7506-9265-6.50017-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
70 Criado MT, Sánchez S, Ferreirós CM. [Classic vaccinology and advances in vaccine design]. Enferm Infecc Microbiol Clin 2008;26:564-72. [PMID: 19100177 DOI: 10.1157/13128274] [Reference Citation Analysis]
71 Offit PA, Boyle DB, Both GW, Hill NL, Svoboda YM, Cunningham SL, Jenkins RJ, McCrae MA. Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. Virology 1991;184:563-8. [PMID: 1653488 DOI: 10.1016/0042-6822(91)90426-c] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
72 Soares-Weiser K, Goldberg E, Tamimi G, Pitan OC, Leibovici L. Rotavirus vaccine for preventing diarrhoea. Cochrane Database Syst Rev 2004;:CD002848. [PMID: 14973994 DOI: 10.1002/14651858.CD002848.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
73 Pongsuwanne Y, Taniguchi K, Choonthanom M, Chiwakul M, Susansook T, Saguanwongse S, Jayavasu C, Urasawa S. Subgroup and serotype distributions of human, bovine, and porcine rotavirus in Thailand. J Clin Microbiol 1989;27:1956-60. [PMID: 2550515 DOI: 10.1128/jcm.27.9.1956-1960.1989] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
74 Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 1991;142:405-11. [PMID: 1663261 DOI: 10.1016/0923-2516(91)90008-q] [Cited by in Crossref: 73] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
75 Mahmud-al-rafat A, Muktadir A, Muktadir H, Karim M, Maheshwari A, Ahasan MM. Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden. Infection 2018;46:15-24. [DOI: 10.1007/s15010-017-1082-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Yasukawa M, Nakagomi O, Kobayashi Y. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin Exp Immunol 1990;80:49-55. [PMID: 2157566 DOI: 10.1111/j.1365-2249.1990.tb06440.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
77 Kapikian AZ, Flores J, Vesikari T, Ruuska T, Madore HP, Green KY, Gorziglia M, Hoshino Y, Chanock RM, Midthun K, Perez-schael I. Recent Advances in Development of a Rotavirus Vaccine for Prevention of Severe Diarrheal Illness of Infants and Young Children. In: Mestecky J, Blair C, Ogra PL, editors. Immunology of Milk and the Neonate. Boston: Springer US; 1991. pp. 255-64. [DOI: 10.1007/978-1-4615-3838-7_34] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
78 Payne DC, Englund JA, Weinberg GA, Halasa NB, Boom JA, Staat MA, Selvarangan R, Azimi PH, Klein EJ, Szilagyi PG, Chappell J, Sahni LC, McNeal M, Harrison CJ, Moffatt ME, Johnston SH, Mijatovic-Rustempasic S, Esona MD, Tate JE, Curns AT, Wikswo ME, Sulemana I, Bowen MD, Parashar UD. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open 2019;2:e1912242. [PMID: 31560386 DOI: 10.1001/jamanetworkopen.2019.12242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
79 Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev 1989;53:410-49. [PMID: 2556635 DOI: 10.1128/mr.53.4.410-449.1989] [Cited by in Crossref: 222] [Cited by in F6Publishing: 261] [Article Influence: 7.2] [Reference Citation Analysis]
80 Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007;26:1099-1104. [PMID: 18043445 DOI: 10.1097/INF.0b013e31814521cb] [Cited by in Crossref: 75] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
81 Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest 1992;90:1984-91. [PMID: 1331178 DOI: 10.1172/JCI116078] [Cited by in Crossref: 247] [Cited by in F6Publishing: 83] [Article Influence: 8.5] [Reference Citation Analysis]
82 Khoury CA, Brown KA, Kim JE, Offit PA. Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. Clin Diagn Lab Immunol 1994;1:722-8. [PMID: 8556527 DOI: 10.1128/cdli.1.6.722-728.1994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
83 Offit PA, Clark H, Ward RL. II, 13. Current state of development of human rotavirus vaccines. Viral Gastroenteritis. Elsevier; 2003. pp. 345-56. [DOI: 10.1016/s0168-7069(03)09020-7] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
84 Offit PA. Rotaviruses: immunological determinants of protection against infection and disease. Adv Virus Res 1994;44:161-202. [PMID: 7817873 DOI: 10.1016/s0065-3527(08)60329-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
85 Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008;21:198-208. [PMID: 18202442 DOI: 10.1128/CMR.00029-07] [Cited by in Crossref: 204] [Cited by in F6Publishing: 69] [Article Influence: 15.7] [Reference Citation Analysis]
86 Taniguchi K, Urasawa T, Kobayashi N, Ahmed MU, Adachi N, Chiba S, Urasawa S. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. J Clin Microbiol 1991;29:483-7. [PMID: 1709946 DOI: 10.1128/jcm.29.3.483-487.1991] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
87 Esposito S, Pugni L, Mosca F, Principi N. Rotarix® and RotaTeq® administration to preterm infants in the neonatal intensive care unit: Review of available evidence. Vaccine 2018;36:5430-4. [DOI: 10.1016/j.vaccine.2017.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Padilla-noriega L, Arias CF, López S, Puerto F, Snodgrass DR, Taniguchi K, Greenberg HB. Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol 1990;28:1114-9. [DOI: 10.1128/jcm.28.6.1114-1119.1990] [Cited by in Crossref: 57] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
89 Grant L, Vinjé J, Parashar U, Watt J, Reid R, Weatherholtz R, Santosham M, Gentsch J, O’brien K. Epidemiologic and Clinical Features of Other Enteric Viruses Associated with Acute Gastroenteritis in American Indian Infants. The Journal of Pediatrics 2012;161:110-115.e1. [DOI: 10.1016/j.jpeds.2011.12.046] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
90 Taterka JA, Cuff CF, Rubin DH. VIRAL GASTROINTESTINAL INFECTIONS. Gastroenterology Clinics of North America 1992;21:303-30. [DOI: 10.1016/s0889-8553(21)00033-9] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
91 Jiang X, Liu Y, Tan M. Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy. Emerg Microbes Infect 2017;6:e22. [PMID: 28400594 DOI: 10.1038/emi.2017.30] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
92 Mrukowicz JZ, Thompson J, Reed GW, Tollefson SJ, Kobayashi M, Araki K, Wright PF. Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination. Vaccine 1999;17:745-53. [PMID: 10067679 DOI: 10.1016/s0264-410x(98)00258-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22:259-267. [PMID: 2371542 DOI: 10.3109/00365549009027046] [Cited by in Crossref: 471] [Cited by in F6Publishing: 447] [Article Influence: 15.2] [Reference Citation Analysis]
94 Brüssow H, Sidoti J, Lerner L, Rahim H, Eckstein W, Werchau H, Mietens C. Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women. J Clin Microbiol 1991;29:2856-9. [DOI: 10.1128/jcm.29.12.2856-2859.1991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
95 Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine 2012;30:A79-85. [DOI: 10.1016/j.vaccine.2012.01.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
96 Brüssow H, Bruttin A, Marc-martin S. Polypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine. J Virol 1990;64:3635-42. [DOI: 10.1128/jvi.64.8.3635-3642.1990] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
97 Ballard SB, Saito M, Mirelman AJ, Bern C, Gilman RH. Tropical and travel-associated norovirus: current concepts. Curr Opin Infect Dis 2015;28:408-16. [PMID: 26237546 DOI: 10.1097/QCO.0000000000000197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
98 Ciarlet M, Schödel F. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq. Vaccine 2009;27 Suppl 6:G72-81. [PMID: 20006144 DOI: 10.1016/j.vaccine.2009.09.107] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
99 Nishikawa K, Hoshino Y, Taniguchi K, Green KY, Greenberg HB, Kapikian AZ, Chanock RM, Gorziglia M. Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology 1989;171:503-15. [PMID: 2474892 DOI: 10.1016/0042-6822(89)90620-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
100 Grant LR, Watt JP, Weatherholtz RC, Moulton LH, Reid R, Santosham M, O'brien KL. Efficacy of a Pentavalent Human-bovine Reassortant Rotavirus Vaccine Against Rotavirus Gastroenteritis Among American Indian Children. Pediatric Infectious Disease Journal 2012;31:184-8. [DOI: 10.1097/inf.0b013e3182435afe] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
101 Kapikian AZ, Flores J, Midthun K, Hoshino Y, Green KY, Gorziglia M, Nishikawa K, Chanock RM, Potash L, Perez-Schael I. Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines. Adv Exp Med Biol 1989;257:67-89. [PMID: 2559615 DOI: 10.1007/978-1-4684-5712-4_9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
102 Bautista-Marquez A, Velasquez DE, Esparza-Aguilar M, Luna-Cruz M, Ruiz-Moran T, Sugata K, Jiang B, Parashar U, Patel M, Richardson V. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants. Vaccine 2016;34:5284-9. [PMID: 27663670 DOI: 10.1016/j.vaccine.2016.09.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
103 Trang NV, Luan LT, Kim-anh LT, Hau VT, Nhung LT, Phasuk P, Setrabutr O, Shirley H, Vinjé J, Anh DD, Mason CJ. Detection and molecular characterization of noroviruses and sapoviruses in children admitted to hospital with acute gastroenteritis in Vietnam. J Med Virol 2012;84:290-7. [DOI: 10.1002/jmv.23185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
104 Ward RL. Rotavirus vaccines: how they work or don't work. Expert Rev Mol Med 2008;10:e5. [PMID: 18267049 DOI: 10.1017/S1462399408000574] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
105 Muñoz Vicente E, Bretón Martínez J, Ros Díez A, Rodríguez García A, Casado Sánchez B, Hernández Marco R, Nogueira Coito J. Gastroenteritis aguda infecciosa en urgencias de un hospital urbano. Anales de Pediatría 2008;68:432-8. [DOI: 10.1157/13120039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Soeorg H, Tamm E, Huik K, Pauskar M, Mägi D, Pruudel K, Vainomäe L, Moosar L, Kirss K, Torm S, Närska M, Pütsepp A, Nurm H, Pruunsild K, Jänes A, Zilmer K, Lutsar I. Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia. Hum Vaccin Immunother 2012;8:465-9. [PMID: 22370511 DOI: 10.4161/hv.19135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
107 Kobayashi N, Taniguchi K, Urasawa S. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3. Arch Virol 1991;117:73-84. [PMID: 1706592 DOI: 10.1007/BF01310493] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Clark A, Jauregui B, Griffiths U, Janusz CB, Bolaños-Sierra B, Hajjeh R, Andrus JK, Sanderson C. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine 2013;31 Suppl 3:C19-29. [PMID: 23777686 DOI: 10.1016/j.vaccine.2013.05.045] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
109 Conner ME, Estes MK, Offit PA, Clark HF, Franco M, Feng N, Greenberg HB. Development of a Mucosal Rotavirus Vaccine. Mucosal Vaccines. Elsevier; 1996. pp. 325-44. [DOI: 10.1016/b978-012410580-5/50026-1] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
110 Fau C, Billaud G, Pinchinat S, Lina B, Kaplon J, Pothier P, Derrough T, Marcelon L, Largeron N, Caulin E, Bellemin B, Cao Nong T, Gaspard C, Mamoux V, Floret D. [Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France]. Arch Pediatr 2008;15:1183-92. [PMID: 18456480 DOI: 10.1016/j.arcped.2008.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
111 Aslan A, Kurugol Z, Cetin H, Karakaşlilar S, Koturoğlu G. Comparison of Vesikari and Clark scales regarding the definition of severe rotavirus gastroenteritis in children. Infectious Diseases 2015;47:332-7. [DOI: 10.3109/00365548.2014.994186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
112 Flores J, Kapikian A, Perez-schael I, Blanco M, White L, Garcia D, Vilar M, Gonzalez R, Urbina C, Boher J, Mendez M, Cunto W. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine. The Lancet 1990;336:330-4. [DOI: 10.1016/0140-6736(90)91876-c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
113 Clark H, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. The Journal of Pediatrics 2004;144:184-90. [DOI: 10.1016/j.jpeds.2003.10.054] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 5.8] [Reference Citation Analysis]
114 Clark HF, Offit PA, Parashar UD. Rotavirus vaccines. Vaccines. Elsevier; 2013. pp. 669-87. [DOI: 10.1016/b978-1-4557-0090-5.00037-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Offit PA, Clark HF. RotaTeq: a pentavalent bovine--human reassortant rotavirus vaccine. Pediatr Ann 2006;35:29-34. [PMID: 16466073 DOI: 10.3928/0090-4481-20060101-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
116 Flores J, Kapikian AZ. Vaccines against viral diarrhoea. Baillière's Clinical Gastroenterology 1990;4:675-93. [DOI: 10.1016/0950-3528(90)90056-m] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
117 Grant L, Watt J, Moulton L, Weatherholtz R, Reid R, Santosham M, O'Brien K. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine. J Pediatr Gastroenterol Nutr 2013;56:635-40. [PMID: 23343932 DOI: 10.1097/MPG.0b013e318287c5cc] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Lewis KD, Dallas MJ, Victor JC, Ciarlet M, Mast TC, Ji M, Armah G, Zaman K, Ferraro A, Neuzil KM. Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. Vaccine 2012;30:A159-66. [DOI: 10.1016/j.vaccine.2011.07.126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
119 Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003;16:17-24. [PMID: 12725685 DOI: 10.1089/088282403763635410] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
120 Kapikian AZ, Vesikari T, Ruuska T, Madore HP, Christy C, Dolin R, Flores J, Green KY, Davidson BL, Gorziglia M. An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. Adv Exp Med Biol 1992;327:59-69. [PMID: 1295353 DOI: 10.1007/978-1-4615-3410-5_8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
121 Conner ME, Matson DO, Estes MK. Rotavirus vaccines and vaccination potential. Curr Top Microbiol Immunol 1994;185:285-337. [PMID: 8050282 DOI: 10.1007/978-3-642-78256-5_10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
122 Parashar UD, Bresee JS, Widdowson M, Gentsch JR. New breath for rotavirus vaccines. Drug Discovery Today: Therapeutic Strategies 2006;3:159-65. [DOI: 10.1016/j.ddstr.2006.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
123 Angel J, Franco MA, Greenberg HB. Rotavirus vaccines: recent developments and future considerations. Nat Rev Microbiol 2007;5:529-39. [PMID: 17571094 DOI: 10.1038/nrmicro1692] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 7.1] [Reference Citation Analysis]
124 Uhnoo I, Riepenhoff-Talty M, Dharakul T, Chegas P, Fisher JE, Greenberg HB, Ogra PL. Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol 1990;64:361-8. [PMID: 2152822 DOI: 10.1128/JVI.64.1.361-368.1990] [Cited by in Crossref: 74] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
125 Levine MM. Vaccines and milk immunoglobulin concentrates for prevention of infectious diarrhea. J Pediatr 1991;118:S129-36. [PMID: 1848888 DOI: 10.1016/s0022-3476(05)81440-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
126 Bernstein DI, Mcneal MM, Schiff GM, Ward RL. Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol 1989;28:90-5. [DOI: 10.1002/jmv.1890280207] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
127 Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Sch??del F, Kaplan KM, Heaton P. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation: . The Pediatric Infectious Disease Journal 2003;22:914-20. [DOI: 10.1097/01.inf.0000091887.48999.77] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
128 Givon-lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine 2008;26:5798-801. [DOI: 10.1016/j.vaccine.2008.08.030] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
129 Clark H, Borian F, Modesto K, Plotkin S. Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. Vaccine 1990;8:327-32. [DOI: 10.1016/0264-410x(90)90089-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
130 Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200 Suppl 1:S39-48. [PMID: 19817613 DOI: 10.1086/605035] [Cited by in Crossref: 164] [Cited by in F6Publishing: 161] [Article Influence: 13.7] [Reference Citation Analysis]
131 O'Neal CM, Crawford SE, Estes MK, Conner ME. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 1997;71:8707-17. [PMID: 9343229 DOI: 10.1128/JVI.71.11.8707-8717.1997] [Cited by in Crossref: 139] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
132 Pérez-Vargas J, Isa P, López S, Arias CF. Rotavirus vaccine: early introduction in Latin America-risks and benefits. Arch Med Res 2006;37:1-10. [PMID: 16314179 DOI: 10.1016/j.arcmed.2005.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
133 Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis. 2009;48:222-228. [PMID: 19072246 DOI: 10.1086/595702] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
134 Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009;9:11. [PMID: 19200366 DOI: 10.1186/1471-2431-9-11] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
135 Sowmyanarayanan TV, Ramani S, Sarkar R, Arumugam R, Warier JP, Moses PD, Simon A, Agarwal I, Bose A, Arora R, Kang G. Severity of rotavirus gastroenteritis in Indian children requiring hospitalization. Vaccine 2012;30 Suppl 1:A167-72. [PMID: 22520127 DOI: 10.1016/j.vaccine.2011.07.145] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
136 Clark HF, Lawley DA, Schaffer A, Patacsil JM, Marcello AE, Glass RI, Jain V, Gentsch J. Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol 2004;42:1434-8. [PMID: 15070985 DOI: 10.1128/JCM.42.4.1434-1438.2004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
137 Vesikari T. Rotavirus vaccines: development and use for the prevention of diarrhoeal disease. Ann Med 1999;31:79-85. [PMID: 10219717 DOI: 10.3109/07853899909019265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
138 Wang Y, Li J, Liu P, Zhu F. The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Hum Vaccin Immunother 2021;17:880-96. [PMID: 32966134 DOI: 10.1080/21645515.2020.1801071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Vesikari T. Rotavirus vaccine studies in Europe. Acta Paediatrica 1999;88:9-13. [DOI: 10.1111/j.1651-2227.1999.tb14319.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
140 D’agostino J. Considerations in Assessing the Clinical Course and Severity of Rotavirus Gastroenteritis. Clin Pediatr (Phila) 2006;45:203-12. [DOI: 10.1177/000992280604500301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
141 Offit PA, Dudzik KI. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol 1990;64:6325-8. [DOI: 10.1128/jvi.64.12.6325-6328.1990] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
142 Heaton P, Goveia M, Miller J, Offit P, Clark H. Development of a Pentavalent Rotavirus Vaccine against Prevalent Serotypes of Rotavirus Gastroenteritis. J INFECT DIS 2005;192:S17-21. [DOI: 10.1086/431500] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
143 Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997;350:1205-9. [PMID: 9652561 DOI: 10.1016/S0140-6736(97)05118-0] [Cited by in Crossref: 207] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
144 Folorunso OS, Sebolai OM. Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines (Basel) 2020;8:E341. [PMID: 32604982 DOI: 10.3390/vaccines8030341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
145 Oldham G, Bridger JC. The effect of dexamethasone-induced immunosuppression on the development of faecal antibody and recovery from and resistance to rotavirus infection. Vet Immunol Immunopathol 1992;32:77-92. [PMID: 1318600 DOI: 10.1016/0165-2427(92)90070-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
146 Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323-332. [PMID: 16860702 DOI: 10.1016/s0140-6736(06)68815-6] [Cited by in Crossref: 312] [Cited by in F6Publishing: 101] [Article Influence: 20.8] [Reference Citation Analysis]
147 Vesikari T, Prymula R, Schuster V, Tejedor JC, Cohen R, Bouckenooghe A, Damaso S, Han HH. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J 2012;31:509-13. [PMID: 22228235 DOI: 10.1097/INF.0b013e3182489cac] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
148 Uhnoo I, Riepenhoff-talty M, Chegas P, Fisher JE, Greenberg HB, Ogra PL. Effect of malnutrition on extraintestinal spread of rotavirus and development of hepatitis in mice. Nutrition Research 1990;10:1419-29. [DOI: 10.1016/s0271-5317(05)80134-4] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
149 Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin Microbiol Rev 1996;9:423-34. [PMID: 8809469 DOI: 10.1128/CMR.9.3.423] [Cited by in Crossref: 88] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
150 Singh-naz N, Rodriguez WJ, Pedreira F. Prospects of a Rotavirus Vaccine. Pediatr Ann 1990;19:727-31. [DOI: 10.3928/0090-4481-19901201-12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
151 Ward RL, Knowlton DR, Greenberg HB, Schiff GM, Bernstein DI. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol 1990;64:2687-91. [PMID: 2159538 DOI: 10.1128/JVI.64.6.2687-2691.1990] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
152 Vesikari T. Rotavirus vaccines against diarrhoeal disease. Lancet. 1997;350:1538-1541. [PMID: 9388411 DOI: 10.1016/s0140-6736(97)03254-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
153 Nakagomi T, Nakagomi O. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix. Expert Opin Biol Ther. 2009;9:1073-1086. [PMID: 19591630 DOI: 10.1517/14712590903103787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
154 Perez-Schael I, Garcia D, Gonzalez M, Gonzalez R, Daoud N, Perez M, Cunto W, Kapikian AZ, Flores J. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol. 1990;30:219-229. [PMID: 2160516 DOI: 10.1002/jmv.1890300315] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 1.8] [Reference Citation Analysis]